Schizophrenia

John H. Krystal, M.D. and Bita Moghaddam). 22. Animal Models of schizophrenia (Barbara K. Lipska and Joseph A. Gogos). Part 3 BIOLOGICAL TREATMENTS. 23. The pharmacology and neuroscience of antipsychotic drugs (John L. Waddington, Colm O'Tuathaigh and Gary J. Remington). 24. Principles of pharmacological treatment in schizophrenia (Thomas R.E. Barnes and Stephen R. Marder). 25. Comparative efficacy and effectiveness in the drug treatment of schizophrenia (John Geddes, Mark Weiser, John M Davis and Grigori Joffe). 26. Approaches to treatment resistant patients (Stefan Leucht, Cristoph U. Correll and John M. Kane). 27. Neurological complications of antipsychotic drugs (Peter M. Haddad and Venkata S. Mattay). 28. Metabolic and other side effects (John W. Newcomer and Stefan Leucht). Part 4 PSYCHOSOCIAL ASPECTS. 29. Schizophrenia and psychosocial stress (Paul E. Bebbington and Elizabeth Kuipers). 30. Mental health services for schizophrenia patients (Tom Burns and Bob Drake). 31. Societal Outcomes in Schizophrenia (Ian Kooyman and Elizabeth Walsh). 32. Psychological treatment of psychosis (Gillian Haddock and Wiliam Spaulding). 33. Economics of the treatment of schizophrenia (Nancy H. Covell, Susan M. Essock, and Linda K. Frisman). Index.

21. Contributions of glutamate and GABA systems to the neurobiology and treatment of schizophrenia (John H. Krystal, M.D. and Bita Moghaddam) ; 22. Animal Models of schizophrenia (Barbara K. Lipska and Joseph A. Gogos) ; Part 3 PHYSICAL TREATMENTS. 23. Pharmacology and neuroscience of antipsychotic drugs (John L. Waddington, Colm O'Tuathaigh and Gary J. Remington) ; 24. Principles of pharmacological treatment in schizophrenia (Thomas R.E. Barnes and Stephen R. Marder) ; 25. Comparative efficacy and effectiveness in the drug treatment of schizophrenia (John Geddes, Mark Weiser, John M Davis and Grigori Joffe) ; 26. Approaches to treatment resistant patients (Stefan Leucht, Cristoph U. Correll and John M. Kane) ; 27. Neurological complications of antipsychotic drugs (Peter M. Haddad and Venkata S. Mattay) ; 28. Metabolic adverse effects associated with antipsychotic medications (John W. Newcomer and Stefan Leucht) ; Part 4 PSYCHOSOCIAL ASPECTS. 29. Schizophrenia and psychosocial stresses (Paul E. Bebbington and Elizabeth Kuipers) ; 30. Mental health services for patients with schizophrenia (Tom Burns and Bob Drake) ; 31. Societal Outcomes in Schizophrenia (Ian Kooyman and Elizabeth …